Zoetis (ZTS) Net Cash Flow Growth (1y) (2013 - 2026)
Zoetis (ZTS) Net Cash Flow Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -117.27% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -167.84% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -290.21% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 270.63% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -367.42% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -7.60% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 272.00% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | 31.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -167.84% |
| Mar 31, 2026 | -44.11% |
| Dec 31, 2025 | -18.88% |
| Sep 30, 2025 | 344.14% |
| Jun 30, 2025 | 42.75% |
| Mar 31, 2025 | -508.33% |
| Dec 31, 2024 | -1.38% |
| Sep 30, 2024 | 291.89% |
| Jun 30, 2024 | -0.51% |
| Mar 31, 2024 | 95.92% |
| Dec 31, 2023 | -73.22% |
| Sep 30, 2023 | 129.13% |
| Jun 30, 2023 | 18.03% |
| Mar 31, 2023 | -314.97% |
| Dec 31, 2022 | 385.65% |
| Sep 30, 2022 | 66.58% |
| Jun 30, 2022 | -1,017.31% |
| Mar 31, 2022 | -17,600.00% |
| Dec 31, 2021 | 498.21% |
| Sep 30, 2021 | -228.81% |